Article Details

Analysts Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.26 EPS

Retrieved on: 2021-04-18 02:15:00

Tags for this article:

Click the tags to see associated articles and topics

Analysts Expect BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to Announce -$0.26 EPS. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo